A Bioavailability Study of NALDEBAIN ER Injection and Nalbuphine Injection in Healthy Volunteers.

NCT04256434 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Health

Interventions

DRUG: Dinalbuphine sebacate
DRUG: Nalbuphine HCl

Sponsor

Lumosa Therapeutics Co., Ltd.